Strains of Bordetellapertussis varied in their ability to elicit (in mice) an antibody bactericidal for an antiserum-sensitive strain of B. pertussis, although antibody was usually detectable after only one injection. High titres were produced by a course of seven injections with all strains of B. pertussis tested (six of phase I and three of phase IV) but not with three strains of other Bordetella species nor with two unrelated organisms, a finding of possible taxonomic value.
INTRODUCTION
Lipopolysaccharide (LPS) of Bordetella pertussis elicits bactericidal antibody active in vitro in the presence of complement against serum-sensitive strains (Pusztai, Csizer & Joo, 1971b; Ackers & Dolby, 1972) . The antigen called here the 'bactericidal antigen' is of interest because it is still present in several artificially-produced variants of B. pertussis and is not one of the many antigens lost on the conversion of phase I organisms to the nutritionally less exacting and antigenically different phase IV (Ackers & Dolby, 1972) . It seemed that the ability to stimulate bactericidal antibody might at times be of help in identifying nutritionally non-exacting, non-fermenting Gram-negative organisms and other derivatives.
Bactericidal antibody was not elicited to the same extent by all strains. We had previously shown (Ackers & Dolby, 1972) that some strains of Bordetella pertussis, e.g. strain 134, either contained less, or a different form, of this antigen than others, and that a single injection of vaccine into mice produced very little bactericidal antibody. Antibody was produced in rabbits by a single injection and in mice after more than four doses. Strain 364, the classical phase IV of Leslie & Gardner (I 93 I ) , also failed to elicit bactericidal antibody consistently. The production in rabbits of bactericidal antibody active against B. pertussis, by other Bordetella species, gave inconsistent results. It therefore seemed worthwhile to see whether the antigen was ubiquitous, and if so explore more fully the ubiquity of the antigen and whether its demonstration could be of any value in classification.
Possible qualitative variations in the antigen possessed by different strains of B. pertussis have also been investigated. Their existence is the more likely because Aprile & Wardlaw (1973a) were able to demonstrate, by in vitro tests, six antigenic determinants on the isolated LPS of Bordetella and related species. By haemagglutination inhibition they J. M. D O L B Y A N D J. P. A C K E R S showed at least four determinants on the surface of B. pertussis, independent of the phase of the strain (Aprile & Wardlaw, 1g73b).
METHODS

Strains.
Bordetella pertussis phase I cultures were stored lyophilized, and grown after reconstitution on Bordet-Gengou medium. Strain I 8-323, the mouse-virulent strain, was originally obtained from Dr P. L. Kendrick (Michigan) and maintained at Elstree by mouse brain passage and lyophilization; strain I34 was from Dr H. Piersma (Lederle Laboratories), and strains 3865 and 3747 were obtained from Dr E. K. Andersen (Copenhagen) and are now available as ~cTcrogo6 and ~cTc19808 from the National Collection of Type Cultures, Central Public Health Laboratories, London NW9 5HT. Strains D734, ~6 2 2 9 and ~3 1 4 8 were isolated in 1967 in Bradford, Manchester and Dundee, respectively, during the Public Health Laboratory Service investigation of whooping cough. Strains ~8 4 and ~2 2 7 5 were similarly received during the Medical Research Council's investigations, and were from Leeds and Cardiff in 1950 and 1953, respectively. These strains represent a cross-section of isolates from three countries from 1930 to 1967 and are of a variety of serotypes.
All other organisms were grown on nutrient agar. Bordetella bronchiseptica strain 22-067 was obtained from Dr G. Eldering (NCTCI0540); other B. bronchiseptica strains were ~~~~8 7 6 0 and ~~~~8 7 6 2 . Bordetella parapertussis strains were NCTC8250 and c803 from the Elstree Collection. Phase IV strains of B. pertussis were 364 (NCTCI0901) and ~8 4 (NCTC-10902), derived at Elstree (from the phase I ~8 4 strain described above) by repeated subculture on media of decreasing complexity until growing well on nutrient agar, and CN2217 similarly derived from strain I 8-323 at Burroughs Wellcome.
Salmonella typhi strains were T4904 and T5501, and Brucella melitensis was strain G I~~E (originally thought to be a phase IV B. pertussis strain, but investigated by ApriIe (1972) as ~CTc863 I and subsequently identified as Brucella melitensis).
Vaccines. Bacterial vaccines were made from 18 h cultures grown at 36 "C on the appropriate solid media and harvested into saline. They were adjusted to the international opacity standard of 10 units and diluted to contain I O~O organisms/ml for all vaccines except Salmonella typhi which contained 109 organisms/ml. For routine use, they were heated at 56 "C, the typhoid vaccine for 60 min, the others for 30 min. Vaccine held in a boiling water bath for 2 h was called 'boiled', and at I 15 lb/in2 for 30 min 'autoclaved'.
Isolated antigens. Lipopolysaccharides (LPS) from Bordetella species coupled to Shigella conjugated protein were prepared by Dr A. P. Maclennan (Maclennan, 1960); LPS from strain ~8 4 phases I and IV (sent to us by Dr L. Szabo), Escherichia coli conjugated protein and B. pertussis endotoxin were all as described previously (Ackers & Dolby, 1972) .
Antiserum preparations. Rabbits were injected intravenously and mice intraperitoneally. Suspensions of whole organisms were given to rabbits as increasing doses, 2 to 3 times a week for the smaller initial ones of I x 109 to 5 x 109 bacteria, decreasing to one dose a week for the larger doses of I O~O organisms. Mice were injected once weekly with a dose of I x 109
to 3 x 109 bacteria. LPS was given similarly to rabbits in increasing doses of 10 to 50 pug. All animals were bled 14 days after the last injection and the separated serum heated at 50 "C for 30 min.
Bactericidal antibody titres. These were determined as described previously (Ackers & Dolby, 1972 ) using a range of antiserum dilutions, guinea-pig serum as the complement source, and the serum-sensitive strain 18-323 phase I as indicator.
Assay .for adjuvant activity. Haemolysin production was used as described previously (Ackers & Dolby, 1972 
RESULTS A N D D I S C U S S I O N
A comparison of the bactericidaf antibody response in rabbits and mice to Bordetefla pertussis and other species Most strains of Bordetella pertussis phases I and IV consistently elicited reasonable titres of bactericidal antibody when injected into rabbits (Table I) . Strain 134, however, produced variable titres; the sera of three of five injected rabbits were not bactericidal at the highest concentration tested, the other two were weakly active at dilutions of 1/2000 to 1/3000. Two strains of B. parapertussis and one of B. bronchiseptica (Table I) produced very low titres, confirming the earlier results of Dolby (1965) that these may be lower than those of some 'normal ' (uninjected) rabbits ; the high titres sometimes found in previously uninjected rabbits are therefore probably not due to natural B. bronchiseptica.
LPS, the 'bactericidal antigen ' from the three Bordetella species pertussis, bronchiseptica and parapertussis, coupled to Shigella conjugated protein were next injected into rabbits with no demonstrable antibody titres before injection, The resulting B. pertussis antisera were far more active than the other two, with titres of about 117680, whereas the maximum for B. parapertussis strain 8250 was 1/120, and there was no activity at 1/30 with antisera to B. bronchispetica strain 8760.
These results suggested that careful selection of rabbits would be necessary to identify Bordetellapertussis independently of phase. Mice had previously been found to produce antibody only weakly or not at all to some strains, e.g. 134, unless vaccination was more extensive than in rabbits, in which antibody was often elicited more easily, if inconsistently. However, mouse sera from all unvaccinated animals had no demonstrable bactericidal activity (Pusztai, Csizer & Joo, 1971 a) .
The number of injections required to produce antibody to a variety of strains was determined from the comparative antibody titres in pooled sera from groups of five mice. All strains of B. pertussis tested, including those which stimulated antibody production poorly or not at all after one dose, produced high titre antisera after 7 doses (Table 2) .
Three doses of strains ~3 1 4 8 and ~2 2 7 3 produced titres as high as three doses of strain ~8 4 phase IV, but three doses of strain 364 elicited antisera which were only weakly active at 1/30. Strain 134 did not elicit bactericidal antibody in mice after 4 doses (Ackers & Dolby, 1972 )- Table 2 . The production of bactericidal antibody by mice; antisera to suspensions of whole organisms following one and seven doses of various heat-killed strains of Bordetella pertussis Injections were given intraperitoneally in 0.1 to 0.5 ml doses. One injection of 2 x log, or seven injections of I x 109 to 3 x 109 organisms were given.
Bacterial antibody (inverse titre) after: The bactericidal antibody titres of 1/3000 or more after 7 injections into mice was specific for B. pertussis. Bordetella parapertussis strain 8250 and B. bronchiseptica strains 7862 and 22-067 gave titres of only I /30. Two unrelated organisms, Brucella melitensis and Salmonella typhi, have been similarly tested and antibody was not detectable at 1/30. It would seem therefore that measurement of bactericidal antibody titre in the sera of mice vaccinated 7 times could distinguish otherwise unidentifiable strains of B. pertussis.
Eflect of boiling and autoclaving on the ability of whole organisms to elicit bactericidal antibody
Subjecting B. pertussis vaccines to roo "C or more impaired the antigenicity of 'bactericidal antigen', in spite of the fact that antibody formation depended on heat-resistant LPS (Ackers & Dolby, 1972) . Vaccines heated at 56 "C for 30 min (the routine treatment) elicited a bactericidal antibody response equal to that of formol-killed or living organisms. Boiling the vaccine for 2 h decreased the antibody response in mice following one injection, although antibody was present after 4 injections, for strains ~7 3 4
and phase I ~8 4
( Table 3) . Results for autoclaved vaccines are few, but this treatment probably impaired the antigen even further (~8 4 phase I and ~~2 2 1 7 phase IV, Table 3 ). Phase IV strains may have more heat labile 'bactericidal antigen' than phase I. The bactericidal antibody eliciting capacity of strains initially low in bactericidal antigen ( 243 Table 3 . The eflect of boiling and autocluving vaccines of B. pertussis on their ubility to elicit bact ericidul antibody Vaccines were exposed to 56 "C for 30 min (heated), or IOO "C for 2 h (boiled) or autoclaved at 15 lb/in2 (120 "C) for 30 min. The sera were raised in mice (given intraperitoneal vaccine) with the exception of those results followed by (R) for which rabbits (vaccinated intravenously) were used.
Since rabbits produced antibody more easily and the significant rabbit antiserum titres were all low, it has been considered valid to use these results. Antibody titres were determined in fourfold dilutions and expressed as the final dilution (inverse titre).
Vaccine made from Heated Boiled if the ' bactericidal antigen' had been completely destroyed. Whether this complete destruction occurred merely because there is less antigen initially in these strains cannot be determined from these results.
The I -and 4-dose mouse antibody titres produced by boiled suspensions of ~8 4 phase I and D734 (Table 3) are very similar to those produced by unboiled suspensions of the low 'bactericidal antigen' strains ~2 2 7 3 , ~3 2 4 8 and 134 (Table 2) . We therefore wondered if the low 'bactericidal antigen' strains had a small amount of the antigen, or whether there were two 'bactericidal antigens ' -one, a good antigen producing high antibody titres after a single dose, but labile to heat, the other heat stable but only producing measurable titres after several doses (the normal strains would possess both antigens, but the 'low antigen' strain only the second). To distinguish between the two hypotheses we attempted bactericidal antibody assays on antiserum to D734 absorbed with boiled homologous suspensions. The absorbed sera were negative for bactericidal antibody even after one absorption, suggesting that boiled suspension could remove all the antibody. The absorbed sera were either anticomplementary, or contained soluble antigen from the absorption which converted the serum-sensitive indicator strain into an insensitive one, as does LPS adsorbed on to the bacterial surface (J. M. Dolby, unpublished) . The results were thus invalid.
We suggested above that the difference between strains eliciting bactericidal antibody early and those which do so only after several injections may be due to the presence of two antigens, one destroyed by heat; this is perhaps made more plausible by the existence of a similar situation in adjuvant activity. Isolated B. pertussis LPS is a heat-stable adjuvant, but the adjuvancy of whole-organism vaccine is much greater than can be accounted for by the content of LPS, and a potent, heat-labile adjuvant has been described (Pieroni & Levine, 1966) . The postulated labile 'bactericidal antigen' cannot be identical with the labile adjuvant, because whole-organism vaccines of strain I 34 (producing bactericidal antibody only after repeated injection) and strains ~6 2 2 9 and ~8 4 phase I (producing antibody after single doses) have indistinguishable activities as adjuvants (Ackers & Dolby, I 972).
